Responsible conduct of research: Preparedness for times of crisis

被引:0
作者
Hahn, Cynthia [1 ]
Kim, Emmelyn [2 ]
Apara, Arinayo O. O. [2 ]
Chuck, Tina [2 ]
Kassan, Hallie [2 ]
Steinberg, Bettie M. M. [3 ,4 ,5 ]
机构
[1] Integrated Res Strategy LLC, Raleigh, NC USA
[2] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA
[3] Northwell Hlth, Feinstein Inst Med Res, Hempstead, NY USA
[4] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA
[5] Northwell Hlth, Feinstein Inst forMed Res, 350 Community Dr, Manhasset, NY 11030 USA
关键词
Clinical research in a pandemic; research integrity; trust in science and medicine;
D O I
10.1017/cts.2023.13
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A live, virtual conference, "Driving Responsible Conduct of Research during a Pandemic," was held in April 2021, 13 months after the COVID-19 pandemic fundamentally altered the conduct of clinical research across the USA. New York was an early epicenter of the US pandemic, highlighting preexisting problems in clinical research and allowing us to assess lessons learned and to identify best practices for the future. Risks and opportunities were categorized broadly into three areas, protecting the welfare and safety of human subjects, ensuring trust in science and medicine, and implementing efficient, ethical, and compliant clinical research. Analysis of conference proceedings, and recent publications, shows a need for preparedness that is more effective, robust partnerships, and organizational systems and standards to strengthen the ethical and responsible conduct of research.
引用
收藏
页数:4
相关论文
共 20 条
  • [1] Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science
    Agley, Jon
    Xiao, Yunyu
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)
  • [2] Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments Observational Cacophony, Randomized Harmony
    Califf, Robert M.
    Hernandez, Adrian F.
    Landray, Martin
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (07): : 625 - 626
  • [3] Health-emergency disaster risk management and research ethics
    Chan, Emily Y. Y.
    Wright, Katharine
    Parker, Michael
    [J]. LANCET, 2019, 393 (10167) : 112 - 113
  • [4] Covid's Color Line - Infectious Disease, Inequity, and Racial Justice
    Evans, Michele K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) : 408 - 410
  • [5] Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges
    Halabi, Susan
    Zhou, Jinyi
    He, Yijie
    Bressler, Linda R.
    Hernandez, Adrian F.
    Turner, Nicholas A.
    Hong, Hwanhee
    [J]. CLINICAL TRIALS, 2022, 19 (05) : 561 - 572
  • [6] On the responsible use of digital data to tackle the COVID-19 pandemic
    Ienca, Marcello
    Vayena, Effy
    [J]. NATURE MEDICINE, 2020, 26 (04) : 463 - 464
  • [7] Towards a More Inclusive and Dynamic Understanding of Medical Mistrust Informed by Science
    Jaiswal, Jessica
    Halkitis, Perry N.
    [J]. BEHAVIORAL MEDICINE, 2019, 45 (02) : 79 - 85
  • [8] National Academy of Medicine, 2022, EM STRONG COVID 19 P
  • [9] Underrepresentation of Hispanics and Other Minorities in Clinical Trials: Recruiters' Perspectives
    Occa, Aurora
    Morgan, Susan E.
    Potter, JoNell E.
    [J]. JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2018, 5 (02) : 322 - 332
  • [10] Pandemic publishing poses a new COVID-19 challenge
    Palayew, Adam
    Norgaard, Ole
    Safreed-Harmon, Kelly
    Andersen, Tue Helms
    Rasmussen, Lauge Neimann
    Lazarus, Jeffrey V.
    [J]. NATURE HUMAN BEHAVIOUR, 2020, 4 (07) : 666 - 669